You are viewing the site in preview mode
Skip to main content
Characteristics
Frequency
Percent
Initial regimen
AZT-3TC-NVP
177
43.2
TDF-3TC-EFV
147
35.9
AZT-3TC-EFV
37
9
TDF-3TC-NVP
28
6.8
D4T(30)-3TC-NVP
16
3.9
D4T(30)-3TC-EFV
3
0.7
ABC-3TC-EFV
2
0.5
Number of ART pill/day
One
128
31.2
Two
201
49
Three
40
9.8
Four
41
10
CPT prophylaxis
Yes
401
97.8
No
9
2.2
Past OI before HARRT initiation
No
295
72
Yes
115
28
Functional status
Working
361
88
Ambulatory
29
7.1
Bed ridden
20
4.9
WHO clinical stage
I
105
25.6
II
73
17.8
III
172
42
IV
60
14.6
CD4 count
<100 cell/mm3
110
26.8
100–199 cell/mm3
150
36.6
200–349 cell/mm3
133
32.4
≥350 cell/mm3
17
4.1
Baseline Hgb
<7 g/dl
8
2
7–9.9 g/dl
37
9
10–12.9 g/dl
173
42.2
≥13 g/dl
192
46.8
Base line weight
<60 kg
318
77.6
≥60 kg
92
22.4